NasdaqCM - Nasdaq Real Time Price USD

Basel Medical Group Ltd (BMGL)

5.09
+1.17
+(29.85%)
At close: June 3 at 4:00:00 PM EDT
4.50
-0.59
(-11.59%)
After hours: June 3 at 7:59:57 PM EDT
Loading Chart for BMGL
  • Previous Close 3.92
  • Open 4.38
  • Bid 4.99 x 1500
  • Ask 5.18 x 1500
  • Day's Range 4.12 - 5.30
  • 52 Week Range 0.91 - 9.40
  • Volume 22,113,655
  • Avg. Volume 4,809,574
  • Market Cap (intraday) 95.62M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 56.56
  • EPS (TTM) 0.09
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as other complex neurosurgical procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions, as well as physiotherapy services. The company was incorporated in 2023 and is headquartered in Singapore.

baselmedical.com

32

Full Time Employees

June 30

Fiscal Year Ends

Recent News: BMGL

View More

Performance Overview: BMGL

Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BMGL
21.48%
S&P 500 (^GSPC)
1.51%

1-Year Return

BMGL
21.48%
S&P 500 (^GSPC)
13.00%

3-Year Return

BMGL
21.48%
S&P 500 (^GSPC)
45.32%

5-Year Return

BMGL
21.48%
S&P 500 (^GSPC)
91.18%

Compare To: BMGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMGL

View More

Valuation Measures

Annual
As of 6/2/2025
  • Market Cap

    73.64M

  • Enterprise Value

    75.45M

  • Trailing P/E

    45.10

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.30

  • Price/Book (mrq)

    12.59

  • Enterprise Value/Revenue

    9.70

  • Enterprise Value/EBITDA

    31.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.58%

  • Return on Assets (ttm)

    8.44%

  • Return on Equity (ttm)

    31.77%

  • Revenue (ttm)

    10.07M

  • Net Income Avi to Common (ttm)

    2.07M

  • Diluted EPS (ttm)

    0.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.04M

  • Total Debt/Equity (mrq)

    75.55%

  • Levered Free Cash Flow (ttm)

    1.43M

Research Analysis: BMGL

View More

Company Insights: BMGL

Research Reports: BMGL

View More

People Also Watch